# HBx Promotes Liver Cancer Cells to Escape NK‐92 Cell Attack by Mediating ADAM10 to Enzyme Cut MICA/B Shedding From Cancer Cell Membrane

**Authors:** Kailin Huang, Qiushi Yin, Xueqin Wu, Kun Liu, Bo Lin, Wei Li, Yinglian Pan, Mingyue Zhu, Mengsen Li

PMC · DOI: 10.1111/jcmm.71081 · 2026-03-06

## TL;DR

This study shows how HBx helps liver cancer cells avoid immune attacks by cutting MICA/B proteins from their surface using ADAM10.

## Contribution

The study reveals a novel mechanism where HBx activates ADAM10 via HIF-1α to shed MICA/B, enabling HCC cells to evade NK-92 cell immunity.

## Key findings

- HBx, MICA/B, and HIF-1α are highly expressed in HBV-infected HCC tissues.
- HBx promotes MICA/B shedding by upregulating ADAM10 activity.
- Inhibiting ADAM10 or HIF-1α restores MICA/B on HCC cell surfaces and enhances NK-92 cell killing.

## Abstract

MICA/B shedding from the membrane of cancer cells can inhibit natural killer (NK) cells from attacking hepatocellular carcinoma (HCC). This study explored the role of HBx in mediating MICA/B shedding. The expression of HBx, MICA/B and HIF‐1α in HBV‐infected HCC was analysed using bioinformatics, and the localization of these proteins in tissues was verified using immunohistochemistry and immunofluorescence. HBx‐related signalling pathways were screened using RNA sequencing and KEGG pathway enrichment analyses. The expression of ADAM10 and MICA/B was detected by Western blotting, and the dynamic changes of MICA/B in the membrane and supernatant were evaluated by flow cytometry and ELISA. The HIF‐1α inhibitor (LW‐6) and ADAM10 inhibitor (GI254023X) were used to treat the HCC cells. The killing effect of NK‐92 cells on HCC cells was evaluated using lactate dehydrogenase release, cytotoxicity assays, clone formation and live‐cell imaging, and the secretion levels of IFN‐γ, IL‐2 and IL‐10 were measured. These results indicated that HBx, MICA/B and HIF‐1α were highly expressed in HBV‐infected HCC tissues. HBx promotes shedding of MICA/B from HCC cell membranes by upregulating the activity of ADAM10. LW‐6 reversed the induction effect of HBx on ADAM10 and GI254023X significantly restored MICA/B levels on the membrane surface of HCC cells. Overexpression of HBx increases the resistance of HCC cells to NK‐92 cells and inhibits the secretion of IFN‐γ, IL‐2 and IL‐10. In conclusion, HBx regulates the expression of ADAM10 by activating the HIF‐1α signalling pathway. ADAM10 cuts MICA/B shedding from the membrane surface of HCC cells, resulting in escape attack by NK‐92 cells.

## Linked entities

- **Genes:** HOX-2.4 (porcine homeobox) [NCBI Gene 407068], MICB (MHC class I polypeptide-related sequence B) [NCBI Gene 450199], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], ADAM10 (ADAM metallopeptidase domain 10) [NCBI Gene 102]
- **Proteins:** MICB (MHC class I polypeptide-related sequence B), HIF1A (hypoxia inducible factor 1 subunit alpha), ADAM10 (ADAM metallopeptidase domain 10)
- **Chemicals:** LW-6 (PubChem CID 16124726), GI254023X (PubChem CID 9952396), IL-2 (PubChem CID 51397006), IL-10 (PubChem CID 146070)
- **Diseases:** hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, MICB (MHC class I polypeptide-related sequence B) [NCBI Gene 4277] {aka PERB11.2}, ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, MICA (MHC class I polypeptide-related sequence A) [NCBI Gene 100507436] {aka MIC-A, PERB11.1}, CXCL16 (C-X-C motif chemokine ligand 16) [NCBI Gene 58191] {aka CXCLG16, SR-PSOX, SRPSOX}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, HBx [NCBI Gene 944566], CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1) [NCBI Gene 476] {aka CMT2DD, HOMGSMR2}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, ADAM10 (ADAM metallopeptidase domain 10) [NCBI Gene 102] {aka AD10, AD18, CD156c, CDw156, HsT18717, MADM}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, HBE1 (hemoglobin subunit epsilon 1) [NCBI Gene 3046] {aka HBE}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, KRT88P (keratin 88, pseudogene) [NCBI Gene 85348] {aka HBC, KRT122P, KRTHBP3}
- **Diseases:** hypoxia (MESH:D000860), carcinogenesis (MESH:D063646), hypoxic (MESH:D002534), HBV (MESH:D006509), Cancer (MESH:D009369), cirrhosis (MESH:D005355), chronic active hepatitis (MESH:D006521), liver diseases (MESH:D008107), Hepatocellular carcinoma (MESH:D006528), non-Hodgkin lymphoma (MESH:D008228), Cytotoxicity (MESH:D064420), infected (MESH:D007239), metastasis (MESH:D009362)
- **Chemicals:** SDS (MESH:D012967), biotin (MESH:D001710), GI254023X (MESH:C555398), polyacrylamide (MESH:C016679), DAPI (MESH:C007293), 3,3-diaminobenzidine (MESH:D015100), paraformaldehyde (MESH:C003043), bicinchoninic acid (MESH:C047117), CO2 (MESH:D002245), haematoxylin (MESH:D006416), puromycin (MESH:D011691), penicillin (MESH:D010406), crystal violet (MESH:D005840), hydrogen peroxide (MESH:D006861), HitransG P virus infection (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PLC/PRF/5 — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_0485), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), HepG2-NC — Homo sapiens (Human), Transformed cell line (CVCL_1874), NK-92 — Homo sapiens (Human), Natural killer cell lymphoblastic leukemia/lymphoma, Cancer cell line (CVCL_2142), HCC — Homo sapiens (Human), Hepatocellular carcinoma, Cancer cell line (CVCL_A1AS), MICA/B — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_B9MQ)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965905/full.md

---
Source: https://tomesphere.com/paper/PMC12965905